ABSTRACT
The objective of this manuscript is to provide the reader with two examples on how to present an immunogenicity risk assessment for a PEGylated therapeutic as part of Investigational New Drug (IND) application or during other stages of the drug development process. In order to provide context to the bioanalytical strategies used to support the PEGylated therapeutics presented here, a brief summary of information available for marketed PEGylated biologics is provided. Two case studies are presented, a PEGylated enzyme and a PEGylated growth factor. For the former, the risk assessment covers how to deal with a narrow therapeutic window and suggestions to utilize a PD marker as surrogate for neutralizing antibody assessments in Phase I. The latter has recommendations on additional analytes that should be monitored to mitigate risk of immunogenicity to endogenous counterparts.
Subject(s)
Antibodies, Neutralizing/immunology , Biological Products/immunology , Hepatocyte Growth Factor/immunology , Phenylalanine Ammonia-Lyase/immunology , Polyethylene Glycols , Succinimides/immunology , Animals , Biological Products/chemistry , Biological Products/toxicity , Drug Compounding , Hepatocyte Growth Factor/chemistry , Hepatocyte Growth Factor/toxicity , Humans , Phenylalanine Ammonia-Lyase/chemistry , Phenylalanine Ammonia-Lyase/toxicity , Polyethylene Glycols/chemistry , Polyethylene Glycols/toxicity , Risk Assessment , Succinimides/chemistry , Succinimides/toxicityABSTRACT
Propamidine is an aromatic diamidine compound. In the current study, baseline sensitivity of Sclerotinia sclerotiorum to propamidine was determined using 78 strains collected from the oilseed rape fields without a previous history of propamidine usage. The median effective concentration (EC50) values for propamidine inhibiting mycelial growth ranged from 0.406 to 3.647µg/mL, with a mean of 1.616±0.217µg/mL. There was no correlation between sensitivity to propamidine and sensitivity to dimethachlon or carbendazim. After treated with propamidine, mycelia were thinner with irregular distortion and more branches; cell wall became thicker with uneven distribution of cytoplasm than untreated control. In addition, sclerotia production, cell membrane permeability and oxalic acid content significantly decreased. On detached oilseed rape leaves, propamidine exhibited better control efficacy than carbendazim at the same concentration whether the leaves were inoculated with carbendazim-sensitive or resistant strains. All the results showed that propamidine exhibited strong antifungal activity and potential application in controlling S. sclerotiorum. Importantly, these data will provide more information on understanding the mode of action of propamidine against S. sclerotiorum and should be valuable for development of new antifungal drugs.
Subject(s)
Ascomycota/drug effects , Benzamidines/toxicity , Fungicides, Industrial/toxicity , Ascomycota/growth & development , Ascomycota/metabolism , Ascomycota/ultrastructure , Benzimidazoles/toxicity , Brassica rapa/microbiology , Carbamates/toxicity , Cell Membrane Permeability , Chlorobenzenes/toxicity , Drug Resistance , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Mycelium/drug effects , Mycelium/growth & development , Mycelium/metabolism , Mycelium/ultrastructure , Oxalic Acid/metabolism , Plant Diseases/microbiology , Plant Diseases/prevention & control , Plant Leaves/microbiology , Succinimides/toxicityABSTRACT
BACKGROUND: Non steroidal anti-inflammatory drugs are the most widely prescribed drugs to manage pain and inflammatory conditions, but their long term use is associated with gastrointestinal toxicity. OBJECTIVES: The study aimed to synthesize an ester-based prodrug of a non steroidal anti-inflammatory agent, mefenamic acid in order to improve the therapeutic index vis a vis to overcome the side effects such as gastrointestinal irritation and bleeding associated with the use of mefenamic acid. METHODS: The ester prodrug (MA-NH) was prepared by condensing mefenamic acid with N-hydroxymethylsuccinimide in the presence of Phosphorus oxychloride. The pharmacokinetic profile, including stability and release of mefenamic acid and N-hydroxymethylsuccinimide from the ester prodrug (MA-NH) was studied by RP- HPLC in acidic medium (pH 1.2), basic medium (pH 7.4), 80 % v/v human plasma, 10 % w/v rat intestinal homogenate and 10 % w/v rat liver homogenate (pH 7.4). RESULTS: The chemical structure of the title compound was characterized by using modern spectroscopic techniques. The prodrug was found to be stable in acid medium, but it hydrolyzed and released sufficient quantities of the drug in alkaline medium. The prodrug produced lesser number of ulcers and showed improved analgesic and anti-inflammatory activity as compared to the parent drug. CONCLUSION: The results indicate that the synthesized prodrug (MA-NH) is better in terms of analgesic and antiinflammatory activities and with less GI toxicity than the parent drug.
Subject(s)
Analgesics/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Mefenamic Acid/analogs & derivatives , Mefenamic Acid/metabolism , Prodrugs/therapeutic use , Succinimides/therapeutic use , Analgesics/chemical synthesis , Analgesics/pharmacokinetics , Analgesics/toxicity , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Anti-Inflammatory Agents, Non-Steroidal/toxicity , Female , Humans , Hydrolysis , Male , Mefenamic Acid/chemical synthesis , Mefenamic Acid/pharmacokinetics , Mefenamic Acid/therapeutic use , Mefenamic Acid/toxicity , Prodrugs/chemical synthesis , Prodrugs/pharmacokinetics , Prodrugs/toxicity , Rats , Rats, Wistar , Succinimides/chemical synthesis , Succinimides/chemistry , Succinimides/pharmacokinetics , Succinimides/toxicity , Ulcer/chemically inducedABSTRACT
Liver damage occurred in some patients who took troglitazone (TGZ) for type II diabetes. The 2,4-thiazolidinedione (TZD) ring in TGZ's structure has been implicated in its hepatotoxicity. To further examine the potential role of a TZD ring in toxicity we used HepG2 cells to evaluate two series of compounds containing different cyclic imides. N-phenyl analogues comprised 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT); 3-(3,5-dichlorophenyl)-2,4-oxazolidinedione (DCPO) and N-(3,5-dichlorophenyl)succinimide (NDPS). Benzylic compounds, which closely resemble TGZ, included 5-(3,5-dichlorophenylmethyl)-2,4-thiazolidinedione (DCPMT); 5-(4-methoxyphenylmethyl)-2,4-thiazolidinedione (MPMT); 5-(4-methoxyphenylmethylene)-2,4-thiazolidinedione (MPMT-I); 5-(4-methoxyphenylmethyl)-2,4-oxazolidinedione (MPMO); 3-(4-methoxyphenylmethyl)succinimide (MPMS) and 3-(4-methoxyphenylmethylene)succinimide (MPMS-I). Cytotoxicity was assessed using the MTS assay after incubating the compounds (0-250µM) with HepG2 cells for 24h. Only certain TZD derivatives (TGZ, DCPT, DCPMT and MPMT-I) markedly decreased cell viability, whereas MPMT had low toxicity. In contrast, analogues without a TZD ring (DCPO, NDPS, MPMO, MPMS and MPMS-I) were not cytotoxic. These findings suggest that a TZD ring may be an important determinant of toxicity, although different structural features, chemical stability, cellular uptake or metabolism, etc., may also be involved. A simple clustering approach, using chemical fingerprints, assigned each compound to one of three classes (each containing one active compound and close homologues), and provided a framework for rationalizing the activity in terms of structure.
Subject(s)
Oxazoles/toxicity , Succinimides/toxicity , Thiazolidinediones/toxicity , Cell Survival/drug effects , Hep G2 Cells , Humans , Oxazoles/chemistry , Structure-Activity Relationship , Succinimides/chemistry , Thiazolidinediones/chemistryABSTRACT
Twenty four new 1-[(4-phenylpiperazin-1-yl)-methyl]- derivatives of 3-phenyl-3-methyl- (6-17) and 3,3-dimethyl-pyrrolidine-2,5-diones (18-29) have been synthesized and evaluated for their anticonvulsant activity in the maximum electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) seizure tests after intraperitoneal injection in mice. The acute neurological toxicity was determined using the rotorod screen. Although no anti-seizure properties were found in the scPTZ screen, fourteen compounds revealed protection in electrically induced seizures. From these molecules seven compounds were tested in rats after oral administration (MES test). In the whole series the most effective in rats were 1-[{4-(4-fluorophenyl)-piperazin-1-yl}-methyl]-3-methyl-3-phenyl-pyrrolidine-2,5-dione (8) with ED50 value of 7.78 mg/kg, it's 3-chlorophenyl- (10) and 3,4-dichlorophenyl- (12) analogs with ED50 values of 27.93 mg/kg and 15.11 mg/kg, respectively. To explain the possible mechanism of action for the most active derivatives 8, 10 and 12 the influence on NaV1.2 sodium channel currents were evaluated in vitro. The results of electrophysiological studies showed higher inhibition of NaV1.2 currents in comparison with phenytoin used as a model antiepileptic drug active in electrically induces seizures. Additionally, eleven 3-phenyl-3-methyl-pyrrolidine-2,5-diones as more promising in the anticonvulsant screening were evaluated in the Vibrio harveyi test to estimate their anti/mutagenic activity.
Subject(s)
Anticonvulsants/chemical synthesis , Anticonvulsants/pharmacology , Succinimides/chemical synthesis , Succinimides/pharmacology , Animals , Anticonvulsants/chemistry , Anticonvulsants/toxicity , Chemistry Techniques, Synthetic , Male , Mannich Bases/chemistry , Mice , Mutagenesis/drug effects , Rats , Safety , Sodium Channels/metabolism , Succinimides/chemistry , Succinimides/toxicity , Vibrio/drug effects , Vibrio/geneticsABSTRACT
Thiazolidinediones have been established as a drug class of significant importance in the treatment of Type II diabetes mellitus and have more recently displayed emergent potential as anti-cancer agents. However, their toxicity has hampered clinical development and usage in both therapeutic areas. Studies to date have implicated that the thiazolidinedione ring is responsible for the generation of reactive metabolites after metabolism. As an attempt to improve their safety profiles, we considered the bioisosteric replacement of the thiazolidinedione ring with a chemically conserved pyrrolidinedione heterocyclic system. Using pyrrolidinedione analogs of the thiazolidinedione drugs troglitazone (TGZ), rosiglitazone (RGZ), and pioglitazone (PGZ), we evaluated their PPAR(γ) activities, anti-cancer properties as well as toxicological effects. Of significance, both pyrrolidinedione analogs demonstrated reduced toxicity. Pharmacologically, they also displayed diminished PPAR(γ) binding and ap2 gene expression in a mouse pre-adipocyte cell line 3T3-L1, but enhanced anti-cancer properties based on the suppression of liver cancer cell line (Huh-7) proliferation and the expression of tumor marker, afp. Overall, this study ascertains the general contribution of the thiazolidinedione ring to their cytotoxicity and proposes the applicability of the pyrrolidinedione ring as a selective and safer choice in anti-diabetic and cancer chemotherapeutics for future drug design.
Subject(s)
Antineoplastic Agents/toxicity , Drug Design , Hypoglycemic Agents/toxicity , Succinimides/toxicity , Thiazolidinediones/toxicity , 3T3-L1 Cells , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , Biotransformation , Caspase 3/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Chromans/toxicity , Dose-Response Relationship, Drug , Fatty Acid-Binding Proteins/genetics , Fatty Acid-Binding Proteins/metabolism , Gene Expression Regulation , Glutathione/metabolism , Humans , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/metabolism , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Mice , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , Molecular Structure , PPAR gamma/agonists , PPAR gamma/metabolism , Phosphorylation , Pioglitazone , Protein Carbonylation/drug effects , Receptor Protein-Tyrosine Kinases/drug effects , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Peptide/metabolism , Rosiglitazone , Structure-Activity Relationship , Succinimides/chemistry , Succinimides/metabolism , Thiazolidinediones/chemistry , Thiazolidinediones/metabolism , TroglitazoneABSTRACT
The agricultural fungicide N-(3,5-dichlorophenyl)succinimide (NDPS) can induce marked nephrotoxicity in rats following a single intraperitoneal (ip) administration of 0.4mmol/kg or greater. Although NDPS induces direct renal proximal tubular toxicity, a role for renal vascular effects may also be present. The purpose of this study was to examine the possible role of vasoconstrictor leukotrienes in NDPS and NDPS metabolite nephrotoxicity. Male Fischer 344 rats (4 rats/group) were administered diethylcarbamazine (DEC; 250 or 500mg/kg, ip), an inhibitor of LTA(4) synthesis, 1h before NDPS (0.4mmol/kg, ip), N-(3,5-dichlorophenyl)-2-hydroxysuccinimide (NDHS, 0.1, 0.2, or 0.4mmol/kg, ip), or N-(3,5-dichlorophenyl)-2-hydroxysuccinamic acid (2-NDHSA, 0.1mmol/kg, ip) or vehicle. In a separate set of experiments, the LTD(4) receptor antagonist LY171883 (100mg/kg, po) was administered 0.5h before and again 6h after NDHS (0.1mmol/kg, ip) or 2-NDHSA (0.1mmol/kg, ip) or vehicle. Renal function was monitored for 48h post-NDPS or NDPS metabolite. DEC markedly reduced the nephrotoxicity induced by NDPS and its metabolites, while LY171883 treatments provided only partial attenuation of NDHS and 2-NDHSA nephrotoxicity. These results suggest that leukotrienes contribute to the mechanisms of NDPS nephrotoxicity.
Subject(s)
Fungicides, Industrial/toxicity , Kidney/drug effects , Leukotrienes/physiology , Succinimides/toxicity , Acetophenones/pharmacology , Animals , Diethylcarbamazine/pharmacology , Injections, Intraperitoneal , Kidney/pathology , Leukotriene A4/metabolism , Leukotriene A4/physiology , Leukotrienes/metabolism , Male , Rats , Rats, Inbred F344 , Receptors, Leukotriene/drug effects , Succinates/pharmacology , Succinimides/pharmacology , Tetrazoles/pharmacologyABSTRACT
Twenty-two new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones were synthesized and tested for anticonvulsant activity. Initial anticonvulsant screening was performed using standard maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) screens in mice. Several compounds were tested additionally in the 6-Hz psychomotor seizure model. The neurotoxicity was determined applying the rotarod test. Excluding one compound, all other molecules were found to be effective in at least one seizure model. The most active were 1-(2-oxo-2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethyl)pyrrolidine-2,5-dione (14), 1-{2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}-3-methylpyrrolidine-2,5-dione (17), 1-{2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}-3,3-dimethylpyrrolidine-2,5-dione (23) and 3,3-dimethyl-1-(2-oxo-2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethyl)pyrrolidine-2,5-dione (26). These compounds showed high activity in the 6-Hz psychomotor seizure test as well as were active in the maximal electroshock and subcutaneous pentylenetetrazole (14 and 23) screens. Initial SAR studies for anticonvulsant activity have been discussed.
Subject(s)
Anticonvulsants/chemical synthesis , Anticonvulsants/pharmacology , Drug Design , Piperazines/chemical synthesis , Piperazines/pharmacology , Piperazines/toxicity , Seizures/prevention & control , Succinimides/chemical synthesis , Succinimides/pharmacology , Succinimides/toxicity , Administration, Oral , Animals , Anticonvulsants/administration & dosage , Anticonvulsants/chemistry , Convulsants , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Electroshock , Ethosuximide/pharmacology , Injections, Intraperitoneal , Mice , Molecular Structure , Motor Activity/drug effects , Pentylenetetrazole , Phenytoin/pharmacology , Piperazines/administration & dosage , Piperazines/chemistry , Rats , Seizures/drug therapy , Structure-Activity Relationship , Succinimides/administration & dosage , Time FactorsABSTRACT
Gelatin nanoparticles, cross-linked by a mixture of a water soluble carbodiimide (CDI) and N-hydroxysuccinimide (NHS) as a non-toxic cross-linking system, was prepared. The conventional two step desolvation method with acetone as the non-solvent was used. The mean size and size distribution as well as the morphology of the formed nanoparticles were evaluated and compared with those of nanoparticles cross-linked by glutaraldehyde (GA) as the most commonly used cross-linking agent. Furthermore, intrinsic viscosities of the nanoparticles cross-linked by CDI/NHS and GA were measured and compared under various conditions. The results showed the formation of smoother and more homogeneous nanoparticles with smaller size when CDI/NHS used as cross-linking agent under the same synthesis condition. Moreover, nanoparticles encapsulating paracetamol as a model drug were produced by the two different cross-linking agents and were characterized for drug entrapment and loading efficiencies and in vitro drug release. Both drug entrapment and loading efficiencies was higher in the CDI/NHS cross-linked nanoparticles; however, the release kinetics was comparable to that of nanoparticles cross-linked with GA. The differences in the characteristics of CDI/NHS and GA cross-linked nanoparticles were attributed to the different nature of network structures formed by the two cross-linking agents. On the whole, these results suggested that CDI/NHS cross-linked nanoparticles have high potential to be used for drug delivery application in preference to the nanoparticles synthesized by toxic cross-linking agents.
Subject(s)
Carbodiimides/pharmacology , Cross-Linking Reagents/pharmacology , Drug Carriers/chemical synthesis , Gelatin/chemistry , Nanoparticles/chemistry , Succinimides/pharmacology , Acetaminophen/administration & dosage , Acetaminophen/pharmacokinetics , Carbodiimides/chemistry , Carbodiimides/toxicity , Cross-Linking Reagents/chemistry , Cross-Linking Reagents/toxicity , Drug Carriers/analysis , Drug Carriers/chemistry , Drug Compounding/methods , Drug Delivery Systems , Gelatin/analysis , Gelatin/chemical synthesis , Hydrogen-Ion Concentration , Microscopy, Electron, Scanning , Nanoparticles/analysis , Particle Size , Succinimides/chemistry , Succinimides/toxicity , Temperature , ViscosityABSTRACT
OBJECTIVE: In order to study the endocrine disrupting effect of dimethachlon (NDPS) (estrogenic and antiandrogenic activity). METHODS: To investigate the estrogenic activity of NDPS by different experiments: (1) Carassius auratus received intraperitoneal injections with NDPS (0, 50, 100 and 200 mg/kg) at regular intervals (5 days) for the synthesis of VTG. The estrogenic effects of the treatment were investigated on VTG in plasma and liver measured by ELISA at 14th. (2) Added the positive control E2 (10(-7) mol/L), and NDPS (10(-10) mol/L, 10(-9) mol/L, 10(-8) mol/L, 10(-7) mol/L, 10(-6) mol/L, 10(-5) mol/L and 10(-4) mol/L) to MCF-7 cells and determinated the proliferation of MCF-7 cells with MTT assay. (3) female mices 18-22 g in weight were castrated, then they were gavaged daily for 5 days with E2 (500 microg/kg) or NDPS (0, 125, 250 and 500 mg/kg) or peanut oil, then uterus was removed and weighed at 6th. Hershberger assay: male SD rats of 4 weeks age were castrated, after 2 weeks, the other groups were dosed daily for 7 days with testosterone propionate (1 mg/kg, sc) plus peanut oil (p.o) or plus NDPS (30 mg/kg, 60 mg/kg and 120 mg/kg, p.o) but one group of castrated rats were subcutaneously injected with peanut oil plus (sc) peanut oil (p.o) as control. Then, the adrenals, prostate, glans penis, seminal vesicle, levator ani and bulbocavernosus muscles were removed and weighed. RESULTS: Compared with control group. There have significantly increase in the plasma VTG concentration in 10 mg/kg of E2 treatment group as well as in 100 mg/kg and 200 mg/kg of NDPS 14 d after injection. In addition, a significantly increase in the liver VTG concentration was observed in the 200 mg/kg of NDPS treatment group. There was no significant alteration of Ca2+, total protein and liver protein content in plasma in all NDPS treatment groups, but E2 increased the plasma Ca2 level, that is higher than the control group. 10(-8) mol/L,10(-7) mol/L and 10(-6) mol/L NDPS could stimulate the proliferation of MCF-7 cell, and there were significant differences compared with control group. All NDPS treatment groups could increase the weight of uterus, but only 250 mg/kg group has signifgicant differences, compared with the control group. In Hershberger assay, relative weight of prostate, seminal vesicle, levator ani and bulbocavernous muscle in 60 mg/kg group and 120 mg/kg group were significantly decreased when compared with those in the control group. CONCLUSION: NDPS exerts endocrine disrupting effect including estrogenic activity and antiandrogenic activity.
Subject(s)
Androgen Antagonists/toxicity , Chlorobenzenes/toxicity , Endocrine Disruptors/toxicity , Estrogens, Non-Steroidal/toxicity , Succinimides/toxicity , Animals , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Female , Goldfish , Humans , Male , Mice , Mice, Inbred ICR , Rats , Rats, Sprague-Dawley , Vitellogenins/analysisABSTRACT
The measurement of cell proliferation after mitogenic stimulation is an important parameter used in diagnosis of immunodeficiencies in clinical laboratory as well as in various fields of lymphocyte research. Recent methods try to overcome the radioactive assay using tritiated thymidine ((3)H) by flow-cytometric methods using different fluorochromes such as CFSE or even to substitute these direct methods by tracing the expression of cell-membrane activation markers associated with various steps of proliferation cycle. In our study we compared the (3)H assay with CFSE-staining method and expression of activation markers (CD69, HLA-DR, CD25, CD27, CD71, CD152, CD134 and CD195) on a sample of 128 consecutive patients and healthy controls evaluated in clinical laboratory. We also tested various concentrations of CFSE and its impact on proliferation activity and expression of activation markers. We found that CFSE in concentration from 37nM to 10microM decreases the proliferative capacity (expressed in cpm (3)H assay) due to the decreased viability of proliferating cells (measured as 7-AAD+) in concentration-dependent manner. Moreover, CFSE substantially modulates the expression of activation molecules (decreasing CD69, HLA-DR, CD25 the majority of examinated molecules). We found a good correlation between CFSE-staining method with (3)H assay, if CFSE low population is gated on CD3+ population (correlation coefficient 0.801), but only in samples with stimulation index (SI) higher then 25. In poorly proliferating samples (SI25) no correlation was found due to several false positive results in CFSE test. Statistically significant correlation between proliferation assessed as (3)H-thymidine incorporation and expression of activation markers was found in the case of CD25, CD27, CD38, CD152, CD71, still only in samples with higher proliferation activity (SI>25). No correlation was found with CD134, CD195, HLA-DR and CD69. We conclude that standard assay with (3)H-thymidine incorporation is unreplaceable assay in diagnosis of severe cellular immunodeficiencies as CFSE assay have high proportion of false positive results. Researchers tracing cell-membrane bound molecules on dividing cells stained by CFSE must take into account that CFSE may substantially modulate the expression of these markers and decrease the viability of stained cells.
Subject(s)
Fluoresceins/toxicity , Fluorescent Dyes/toxicity , Immunologic Deficiency Syndromes/diagnosis , Immunologic Deficiency Syndromes/immunology , Lymphocyte Activation/drug effects , Lymphocytes/drug effects , Lymphocytes/immunology , Succinimides/toxicity , Antigens, CD/metabolism , Case-Control Studies , Cell Division/drug effects , Cell Survival/drug effects , False Positive Reactions , Flow Cytometry , HLA-DR Antigens/metabolism , Humans , In Vitro Techniques , Lymphocytes/metabolism , Lymphocytes/pathology , Thymidine/metabolism , TritiumABSTRACT
The synthesis and anticonvulsant properties of new 1-(2-pyridinyl)- succinimides [I-XXII] differently substituted at the position-3 of imide ring have been described. The profile of pharmacological activity of these compounds was examined by a maximal electroshock (MES) and pentylenetetrazole (scPTZ) tests, whereas their neurotoxicity was determined using a rotarod screen. The results obtained revealed that the anticonvulsant activity depended mainly on the kind of substituents at the position-3 of pyrrolidine-2,5-dione ring. The most active were 3,3-dialkyl-pyrrolidine-2,5-diones [IX-XVIII] as well as compounds with 3-methylcyclohexane moiety as a spiro nucleus at position-3 of the imide ring [I-IV]. The 3-cyclohexylsuccinimides [V-VIII] with cyclohexane ring as a flexible fragment were less active, whereas unsubstituated derivatives [XIX-XXII] were devoid of activity in both tests applied. In addition, the anti-seizure protection depended on the position of methyl group at the pyridine moiety. The most potent were compounds with the methyl substituent at the position-4 [II, VI, XVII] or -6 [XI, XIV]. It should be noted, that in the whole series the most active was 1-(4-methyl-2-pyridinyl)-3-cyclohexyl-pyrrolidne-2,5-dione [VI], which showed the anti-scPTZ protection at the dose of 30 mg/kg.
Subject(s)
Anticonvulsants/chemical synthesis , Succinimides/chemical synthesis , Animals , Anticonvulsants/pharmacology , Anticonvulsants/toxicity , Male , Mice , Rats , Structure-Activity Relationship , Succinimides/pharmacology , Succinimides/toxicityABSTRACT
The agricultural fungicide N-(3,5-dichlorophenyl)succinimide (NDPS) is a more potent nephrotoxicant in female rats than in males. Similarly, nephrotoxicant NDPS metabolites studied to date in male and female rats have also demonstrated gender differences, being twice as potent as nephrotoxicants in females as in males. The purpose of this study was to examine the nephrotoxic potential of N-(3,5-dichlorophenyl)-3-hydroxysuccinimide (3-NDHSA) in male and female Fisher 344 rats to determine if gender differences in nephrotoxic potential also exist for this metabolite. Rats (four per group) were administered a single intraperitoneal (i.p.) injection of 3-NDHSA (0.1, 0.2 or 0.4 mmol kg(-1)) or vehicle, and renal function was monitored at 24 and 48 h. 3-NDHSA 0.1 mmol kg(-1) did not induce nephrotoxicity in male or female rats. In male rats, 3-NDHSA 0.2 mmol kg(-1) induced mild nephrotoxicity seen as diuresis and transient, mild proteinuria. However, 3-NDHSA 0.4 mmol kg(-1) induced marked nephrotoxicity. In female rats, 3-NDHSA 0.2 mmol kg(-1) induced mild nephrotoxicity, as evidenced by transient diuresis and proteinuria. As in males, 3-NDHSA 0.4 mmol kg(-1) induced marked nephrotoxicity. These results indicate that, unlike NDPS and other nephrotoxic NDPS metabolites, 3-NDHSA does not exhibit gender differences in nephrotoxic potential. In addition, in comparison with NDPS and other nephrotoxic NDPS metabolites, 3-NDHSA is a less potent nephrotoxicant that NDHS or 2-NDHSA and similar to NDPS in nephrotoxic potential in male rats.
Subject(s)
Fungicides, Industrial/toxicity , Kidney Diseases/chemically induced , Kidney/drug effects , Succinimides/toxicity , Animals , Diuresis/drug effects , Diuresis/physiology , Dose-Response Relationship, Drug , Female , Injections, Intraperitoneal , Kidney/pathology , Kidney/physiopathology , Kidney Diseases/pathology , Kidney Diseases/physiopathology , Kidney Function Tests , Male , Organ Size/drug effects , Proteinuria/chemically induced , Proteinuria/physiopathology , Rats , Rats, Inbred F344 , Sex FactorsABSTRACT
The agricultural fungicide N-(3,5-dichlorophenyl)succinimide (NDPS) induces nephrotoxicity characterized as polyuric renal failure and mediated via metabolites arising from oxidation of the succinimide ring. Recent findings have suggested that the stereochemical nature of NDPS metabolites may be an important factor in NDPS metabolite-induced nephrotoxicity. The purpose of the present study was to determine the role of stereochemistry in the in vivo nephrotoxicity induced by R-(+)- and S-(-)-N-(3,5-dichlorophenyl)-2-hydroxysuccinimide (R- and S-NDHS) and the in vitro nephrotoxicity induced by their enantiomeric sulfate conjugates, R-(-)- and S-(+)-N-(3,5-dichlorophenyl)-2-hydroxysuccinimide-O-sulfate (R- and S-NSC). Male Fischer 344 rats (four rats/group) were administered intraperitoneally (i.p.) an enantiomer of NDHS (0.05, 0.1 or 0.2 mmol/kg) or vehicle, and renal function monitored for 48 h. R-NDHS (0.1 or 0.2 mmol/kg) had little effect on renal function. In contrast, S-NDHS (0.1 mmol/kg) induced marked nephrotoxicity. The nephrotoxic potential of R- and S-NSC (0.5, 0.75 or 1.0mM) was determined using freshly isolated rat renal cortical cells (IRCC, 3-4 x 10(6)cells/ml). Cytotoxicity was determined by measuring the release of lactate dehydrogenase (LDH) at the end of a 1h incubation period. The LDH release observed in these studies was similar between R- and S-NSC. These results indicate that stereochemistry is an important factor for NDPS metabolite nephrotoxicity and that the role of stereochemistry, at least for NSC, occurs at extra-renal sites.
Subject(s)
Kidney Cortex/drug effects , Kidney Diseases/chemically induced , Succinimides/toxicity , Sulfuric Acid Esters/toxicity , Animals , Cell Survival/drug effects , Cells, Cultured , Kidney Cortex/cytology , Kidney Cortex/pathology , Kidney Diseases/pathology , Kidney Diseases/urine , Kidney Function Tests , Male , Rats , Rats, Inbred F344 , Stereoisomerism , Succinimides/chemistry , Succinimides/urine , Sulfuric Acid Esters/chemistry , Sulfuric Acid Esters/urineABSTRACT
The developmental toxicity of the three main metabolites of N-methyl-2-pyrrolidone (NMP) was studied in Sprague-Dawley rats. Pregnant rats were given 5-hydroxy-N-methyl-2-pyrrolidone (5-HNMP; 0, 250, 500, 750 or 1000 mg kg(-1) day(-1)), N-methylsuccinimide (MSI; 0, 500, 750, 1000 or 1250 mg kg(-1) day(-1)), or 2-hydroxyN-methylsuccinimide (2-HMSI; 0, 250, 500, 1000 or 1500 mg kg(-1) day(-1)), by gavage, on gestational days (GD) 6-20. No evidence of maternal toxicity was observed in dams given 5-HNMP. Administration of 2-HMSI resulted in overt maternal toxicity at 500 mg kg(-1) day(-1) and higher doses, as indicated by a significant reduction in weight gain and food consumption at the beginning of treatment. There was no evidence of embryo/fetal toxicity in any of the groups treated with 5-HNMP or 2-HMSI. MSI produced marked developmental toxicity in the presence of maternal effects. Maternal body weight gain and food consumption were affected at 750 mg kg(-1) day(-1) MSI, and above. A significant increase in post-implantation loss occurred at 1250 mg kg(-1) day(-1) MSI, and the incidence of fetuses with external or with visceral malformations was significantly increased at 1000 and 1250 mg kg(-1) day(-1) MSI. Malformations mainly consisted of anasarca, cardiovascular defects and diaphragmatic hernia. Fetal weight was significantly reduced at 1000 and 1250 mg kg(-1) day(-1). The incidence of skeletal variations (predominantly cervical ribs, and delayed ossification of skull bones and sternebrae) was significantly elevated at 750 mg kg(-1) day(-1) and higher doses. However, MSI was much less potent than the parent compound. These results indicate that the embryotoxic and teratogenic effects of NMP are not attributable to these metabolites.
Subject(s)
Abnormalities, Drug-Induced , Fetal Death/chemically induced , Fetus/drug effects , Pyrrolidinones/toxicity , Solvents/toxicity , Succinimides/toxicity , Administration, Oral , Animals , Biotransformation , Body Weight/drug effects , Bone and Bones/abnormalities , Bone and Bones/drug effects , Cardiovascular Abnormalities/chemically induced , Dose-Response Relationship, Drug , Eating/drug effects , Embryonic Development/drug effects , Female , Fetal Weight/drug effects , Gestational Age , Hernia, Diaphragmatic/chemically induced , Pregnancy , Pyrrolidinones/administration & dosage , Pyrrolidinones/metabolism , Rats , Rats, Sprague-Dawley , Solvents/administration & dosage , Solvents/metabolism , Succinimides/administration & dosage , Succinimides/metabolismABSTRACT
Antiandrogens can cause reproductive disorders in humans and wild animals. In the present study, we tested whether the fungicide N-(3, 5-dichlorophenyl) succinimide (NDPS) acts as an antiandrogen using in vitro and in vivo assays. A transient transfection system based on luciferase activity was utilized for in vitro analysis of the antiandrogeic activity of NDPS. Hershberger assay was used to analyze the antiandrogenic activity of NDPS in rats. The expressions of the androgen-responsive genes testosterone-repressed prostatic message-2 (TRPM-2) and prostate specific binding protein polypeptide C3 (PBP C3) in the rat ventral prostate were measured using real-time PCR. Our results indicated that NDPS can block 5-dehydrotestosterone (DHT)-induced androgen receptor (AR) activity in transiently transfected HepG2 cells (-5 log M). In the Hershberger assay, the weights of the seminal vesicles and levator ani/bulbocavernosus muscles were significantly decreased (P<0.05) in all NDPS groups, and the weights of the ventral prostate, dorsolateral prostate, and Cowper's glands were significantly decreased (P<0.05) in the 100 and 200 mg/kg NDPS groups. NDPS only decreased (P<0.05) the expression of PBP C3 and had no effect on the level of TRPM-2 (P>0.05). In conclusion, NDPS is a moderate antiandrogen that elicits antiandrogenic effects at least partly by antagonizing AR and increasing the expression of PBP C3.
Subject(s)
Androgen Receptor Antagonists , Clusterin/metabolism , Fungicides, Industrial/toxicity , Genitalia, Male/drug effects , Peptides/metabolism , Succinimides/toxicity , Animals , Body Weight/drug effects , Cell Line , Clusterin/genetics , Gene Expression/drug effects , Genes, Reporter , Genitalia, Male/pathology , Humans , Immunohistochemistry , Male , Organ Size/drug effects , Peptides/genetics , Polymerase Chain Reaction , Rats , Rats, Sprague-Dawley , Testosterone/metabolism , TransfectionABSTRACT
Adipose tissue engineering with preadipocyte-loaded scaffolds requires adequate tracking of preadipocytes to allow evaluation and quantification of cell proliferation, expansion and differentiation in three-dimensional systems. To differentiate between graft and host cells, labeling of preadipocytes before implantation and tracking of these cells until harvest would be useful. Immunohistochemistry enables the differentiation between cells of different species but is time-consuming, expensive, elaborate, and not applicable for autologous transplantation. So far, there is no published method to use externally applied dyes for tracking of human preadipocytes in adipose tissue engineering. We tested the cell dyes PKH26, CM-DiI, and CFSE to analyze their applicability for labeling human preadipocytes. CM-DiI had toxicity levels of 45-70%, while 3-4% proliferating cells were stained on day 35. CFSE revealed clear cytoplasmic coloring in proliferating cells with 5-6% stained cells after 35 days and toxicity ranging from 55 to 90% dead cells. PKH26 demonstrates lowest levels of toxicity and best labeling results after 4 weeks in proliferating preadipocytes in monolayer. Although none of the dyes showed long-lasting labeling during proliferation, all three dyes demonstrated permanent staining in differentiated cells. The results reveal the problems of preadipocyte tracking with fluorescent dyes but justify the dye application for limited time periods.
Subject(s)
Adipocytes/cytology , Adipocytes/physiology , Fluorescent Dyes , Tissue Engineering/methods , Adipocytes/drug effects , Adult , Carbocyanines/toxicity , Cell Culture Techniques/methods , Fluoresceins/toxicity , Fluorescent Dyes/toxicity , Humans , Organic Chemicals/toxicity , Succinimides/toxicityABSTRACT
The agricultural fungicide N-(3,5-dichlorophenyl)succinimide (NDPS) is nephrotoxic in rats. Due to the involvement of NDPS metabolism in its mechanism of toxicity, the detailed biotransformation of 14C-NDPS in rats was previously evaluated using high-performance liquid chromatography-electrospray ionization-mass spectrometry. In the present report, we describe the identification of two novel amino metabolites of NDPS, which were present in significant amounts in rat kidney tissues. Using liquid chromatography-tandem mass spectrometry and synthetic standards, the two metabolites were identified as N-(3,5-dichlorophenyl)-2-aminosuccinamic acid (2-NDASA) and its N-acetylated derivative (N-acetyl-2-NDASA). The mechanism of formation of 2-NDASA was studied in vitro. Incubations were carried out in rat liver and kidney cytosols using the major oxidative metabolite of NDPS, N-(3,5-dichlorophenyl)-2-hydroxysuccinamic acid, as the substrate. Formation of 2-NDASA in vitro was confirmed using mass spectrometry. Inhibitors of alcohol dehydrogenase (4-methylpyrazole) and aldehyde dehydrogenase (disulfiram) reduced 2-NDASA formation by 40 to 50%. Menadione (an inhibitor of aldehyde oxidase) and quercetin (an inhibitor of carbonyl reductase) did not show any effects. (Aminooxy)acetic acid, an inhibitor of pyridoxal 5'-phosphate-containing enzymes such as aminotransferases, almost completely abolished the formation of 2-NDASA. Using liquid chromatography-mass spectrometry, the transamination mechanism was further supported by the incorporation of a 15N-amino group in 2-NDASA when 15N-glutamic acid was included in the incubation mixture. Results from these studies show that transamination is a metabolic pathway in the clearance of NDPS in rats, and that cytosolic dehydrogenases and aminotransferases may be involved in this process.
Subject(s)
Fungicides, Industrial/metabolism , Succinimides/metabolism , Animals , Kidney/drug effects , Liver/metabolism , Male , Mass Spectrometry , Rats , Rats, Inbred F344 , Succinimides/toxicityABSTRACT
Our objective was to study the properties of the carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) and the methodology of cell labeling using CFDA-SE fluorescent dye. First, we analyzed the kinetics of CFDA-SE fluorescent dye intensity over time. Second, we determined the optimal concentration of CFDA-SE fluorescent dye for cell labeling. Third, we tested the toxicity of CFDA-SE fluorescent dye on labeled cells. Finally, we determined the optimal staining time of CFDA-SE fluorescent dye for cell labeling. The results show that the optimal concentration of CFDA-SE fluorescent dye for cell labeling varies according to different cell types. CFDA-SE fluorescent dye is non-toxic to cells as the cell death rate caused by CFDA-SE labeling is below 5%. The optimal cell labeling time was determined to be 8 min of incubation with CFDA-SE fluorescent dye. We concluded that the advantages of using CFDA-SE fluorescent dye for cell labeling are as follows: (1) the binding of CFDA-SE fluorescent dye to cells is stable; (2) CFDA-SE fluorescent dye is not toxic and does not modify the viability of labeled cells; and (3) CFDA-SE fluorescent dye is a suitable fluorochrome for cell labeling.
Subject(s)
Cytological Techniques , Fluoresceins , Fluorescent Dyes , Staining and Labeling/methods , Succinimides , Animals , Cell Death/drug effects , Cell Line, Tumor , Flow Cytometry , Fluoresceins/chemistry , Fluoresceins/toxicity , Fluorescent Dyes/chemistry , Humans , Succinimides/chemistry , Succinimides/toxicityABSTRACT
The succinimide ring is incorporated into hundreds of compounds that are widely used as agricultural, industrial, and pharmaceutical agents. Some succinimide derivatives that contain an aryl group on the ethylene bridge of the succinimide ring (C-arylsuccinimides) or on the nitrogen atom (N-arylsuccinimides) induce nephrotoxicity in humans and/or laboratory animals. Acute toxicity induced by this general class of compounds is typically characterized as polyuric renal failure, while chronic nephrotoxicity is seen as chronic interstitial nephritis. In this review, the structure-nephrotoxicity relationships, biotransformation, and mechanisms of nephrotoxicity for the C- and N-arylsuccinimides are examined.